Ina Rothenaigner

1.6k total citations
27 papers, 1.0k citations indexed

About

Ina Rothenaigner is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Virology. According to data from OpenAlex, Ina Rothenaigner has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Virology. Recurrent topics in Ina Rothenaigner's work include HIV Research and Treatment (4 papers), Computational Drug Discovery Methods (4 papers) and Neonatal Respiratory Health Research (4 papers). Ina Rothenaigner is often cited by papers focused on HIV Research and Treatment (4 papers), Computational Drug Discovery Methods (4 papers) and Neonatal Respiratory Health Research (4 papers). Ina Rothenaigner collaborates with scholars based in Germany, United States and United Kingdom. Ina Rothenaigner's co-authors include Kamyar Hadian, Ruth Brack‐Werner, Horst Wolff, Jeanne E. Bell, Kenji Schorpp, Ravi Jagasia, Laure Bally‐Cuif, Mónika Krecsmarik, Gilles Fortin and Magdalena Götz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Ina Rothenaigner

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ina Rothenaigner Germany 16 463 255 140 138 137 27 1.0k
Sebastian Breuer Germany 15 749 1.6× 181 0.7× 28 0.2× 94 0.7× 51 0.4× 25 1.3k
Huiyi Miao United States 13 744 1.6× 225 0.9× 55 0.4× 20 0.1× 55 0.4× 20 1.8k
Raymond Wong Canada 22 667 1.4× 130 0.5× 116 0.8× 35 0.3× 35 0.3× 45 1.3k
Hermann C. Altmeppen Germany 23 1.1k 2.3× 64 0.3× 527 3.8× 17 0.1× 152 1.1× 53 1.6k
Chun‐Teng Huang Taiwan 19 617 1.3× 23 0.1× 28 0.2× 85 0.6× 159 1.2× 47 1.2k
Mark G. H. Scott France 26 1.3k 2.9× 38 0.1× 70 0.5× 25 0.2× 88 0.6× 42 1.8k
Mohammad Fallahi United States 26 1.2k 2.7× 173 0.7× 68 0.5× 6 0.0× 272 2.0× 41 1.9k
Elena Zaslavsky United States 20 1.2k 2.5× 19 0.1× 111 0.8× 20 0.1× 187 1.4× 39 1.8k
Brett Marshall United States 10 1.2k 2.6× 137 0.5× 17 0.1× 21 0.2× 59 0.4× 11 2.2k

Countries citing papers authored by Ina Rothenaigner

Since Specialization
Citations

This map shows the geographic impact of Ina Rothenaigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Rothenaigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Rothenaigner more than expected).

Fields of papers citing papers by Ina Rothenaigner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Rothenaigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Rothenaigner. The network helps show where Ina Rothenaigner may publish in the future.

Co-authorship network of co-authors of Ina Rothenaigner

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Rothenaigner. A scholar is included among the top collaborators of Ina Rothenaigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Rothenaigner. Ina Rothenaigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tonnus, Wulf, Francesca Maremonti, Mami Sato, et al.. (2024). Seratrodast inhibits ferroptosis by suppressing lipid peroxidation. Cell Death and Disease. 15(11). 853–853. 6 indexed citations
2.
Nair, Vidya Padmanabhan, Gabriele Ciceri, Ina Rothenaigner, et al.. (2024). Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development. Nature Communications. 15(1). 7611–7611. 23 indexed citations
3.
Yang, Xiaohua, Ina Rothenaigner, Marina Bullo, et al.. (2024). Cyclosporine A in children with ABCA3 deficiency. Pediatric Pulmonology. 59(12). 3221–3227. 2 indexed citations
4.
Yang, Xiaohua, Christina Rapp, Ina Rothenaigner, et al.. (2023). ABCA3 Deficiency—Variant-Specific Response to Hydroxychloroquine. International Journal of Molecular Sciences. 24(9). 8179–8179. 5 indexed citations
5.
Rothenaigner, Ina, Constanze Müller, Roman Graf, et al.. (2023). Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis. Nature Communications. 14(1). 6908–6908. 57 indexed citations
6.
Rothenaigner, Ina, et al.. (2022). High-content screen identifies cyclosporin A as a novel ABCA3-specific molecular corrector. Klinische Pädiatrie. 234(5). 344–345.
7.
Dahlin, Jayme L., Douglas S. Auld, Ina Rothenaigner, et al.. (2021). Nuisance compounds in cellular assays. Cell chemical biology. 28(3). 356–370. 33 indexed citations
8.
Iturbide, Ane, Kenji Schorpp, Ina Rothenaigner, et al.. (2021). Retinoic acid signaling is critical during the totipotency window in early mammalian development. Nature Structural & Molecular Biology. 28(6). 521–532. 44 indexed citations
9.
Rothenaigner, Ina & Kamyar Hadian. (2021). Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns. SLAS DISCOVERY. 26(7). 851–854. 14 indexed citations
10.
Nair, Vidya Padmanabhan, Gabriele Ciceri, Johannes Jungverdorben, et al.. (2021). Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3. Cell stem cell. 28(9). 1566–1581.e8. 34 indexed citations
11.
Schorpp, Kenji, et al.. (2020). Image-based high-content screening in drug discovery. Drug Discovery Today. 25(8). 1348–1361. 65 indexed citations
12.
Brenke, Jara Kerstin, Grzegorz M. Popowicz, Kenji Schorpp, et al.. (2018). Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity. Journal of Biological Chemistry. 293(34). 13191–13203. 57 indexed citations
13.
Brenke, Jara Kerstin, E.S. Salmina, Maria Kuzikov, et al.. (2016). Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase–Glutathione Interaction. SLAS DISCOVERY. 21(6). 596–607. 16 indexed citations
14.
Rothenaigner, Ina, et al.. (2016). A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein–Protein Interaction Inhibitors. SLAS DISCOVERY. 22(3). 316–323. 5 indexed citations
15.
Schorpp, Kenji, Ina Rothenaigner, Julia Maier, et al.. (2016). A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living Cells. SLAS DISCOVERY. 21(9). 965–977. 16 indexed citations
16.
Anastasov, Nataša, Ines Höfig, Vanja Radulović, et al.. (2015). A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment. BMC Cancer. 15(1). 466–466. 41 indexed citations
17.
Vincendeau, Michelle, Kamyar Hadian, Ina Rothenaigner, et al.. (2010). Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp). AIDS. 24(16). 2433–2442. 27 indexed citations
18.
Brack‐Werner, Ruth, Susanne Krämer, Kamyar Hadian, et al.. (2009). Identification of a novel family of human proteins that restrict HIV replication in astrocytes by targeting Rev. 15. 11–11. 1 indexed citations
19.
Rothenaigner, Ina, et al.. (2007). Long-term HIV-1 infection of neural progenitor populations. AIDS. 21(17). 2271–2281. 44 indexed citations
20.
Rothenaigner, Ina, et al.. (2005). Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Research. 111(2). 194–213. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Breuer Breakdown of academic impact, for papers by Huiyi Miao Breakdown of academic impact, for papers by Raymond Wong Breakdown of academic impact, for papers by Hermann C. Altmeppen Breakdown of academic impact, for papers by Chun‐Teng Huang Breakdown of academic impact, for papers by Mark G. H. Scott Breakdown of academic impact, for papers by Mohammad Fallahi Breakdown of academic impact, for papers by Elena Zaslavsky Breakdown of academic impact, for papers by Brett Marshall
Rankless by CCL
2026